BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21070126)

  • 21. Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation.
    Girerd B; Montani D; Coulet F; Sztrymf B; Yaici A; Jaïs X; Tregouet D; Reis A; Drouin-Garraud V; Fraisse A; Sitbon O; O'Callaghan DS; Simonneau G; Soubrier F; Humbert M
    Am J Respir Crit Care Med; 2010 Apr; 181(8):851-61. PubMed ID: 20056902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia.
    Grünig E; Weissmann S; Ehlken N; Fijalkowska A; Fischer C; Fourme T; Galié N; Ghofrani A; Harrison RE; Huez S; Humbert M; Janssen B; Kober J; Koehler R; Machado RD; Mereles D; Naeije R; Olschewski H; Provencher S; Reichenberger F; Retailleau K; Rocchi G; Simonneau G; Torbicki A; Trembath R; Seeger W
    Circulation; 2009 Apr; 119(13):1747-57. PubMed ID: 19307479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
    Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
    Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BMPR2 gene mutation in pulmonary arteriovenous malformation and pulmonary hypertension: a case report.
    Handa T; Okano Y; Nakanishi N; Morisaki T; Morisaki H; Mishima M
    Respir Investig; 2014 May; 52(3):195-8. PubMed ID: 24853021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
    Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
    Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bone morphogenetic protein type II receptor gene promoter mutation-142G > A in a patient with familial pulmonary arterial hypertension].
    Li W; Hu H
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):230-4. PubMed ID: 19552837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel mutation in the BMPR2 gene in familial pulmonary arterial hypertension.
    Fu LJ; Zhou AQ; Huang MR; Shen SH; Shen J; Zhang ZF; Li F
    Chin Med J (Engl); 2008 Mar; 121(5):399-404. PubMed ID: 18364108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted gene delivery of BMPR2 attenuates pulmonary hypertension.
    Reynolds AM; Holmes MD; Danilov SM; Reynolds PN
    Eur Respir J; 2012 Feb; 39(2):329-43. PubMed ID: 21737550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel mutations in BMPR2, ACVRL1 and KCNA5 genes and hemodynamic parameters in patients with pulmonary arterial hypertension.
    Pousada G; Baloira A; Vilariño C; Cifrian JM; Valverde D
    PLoS One; 2014; 9(6):e100261. PubMed ID: 24936649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moderate altitude increases right ventricular pressure and oxygen desaturation in adolescents with surgically closed septal defect.
    Möller T; Brun H; Fredriksen PM; Holmstrøm H; Pettersen E; Thaulow E
    Congenit Heart Dis; 2010; 5(6):556-64. PubMed ID: 21106015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetics and genomics of pulmonary arterial hypertension.
    Machado RD; Eickelberg O; Elliott CG; Geraci MW; Hanaoka M; Loyd JE; Newman JH; Phillips JA; Soubrier F; Trembath RC; Chung WK
    J Am Coll Cardiol; 2009 Jun; 54(1 Suppl):S32-S42. PubMed ID: 19555857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BMPR2 gene therapy for PAH acts via Smad and non-Smad signalling.
    Harper RL; Reynolds AM; Bonder CS; Reynolds PN
    Respirology; 2016 May; 21(4):727-33. PubMed ID: 26809239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and molecular genetic features of hereditary pulmonary arterial hypertension.
    Brenner L; Chung WK
    Compr Physiol; 2011 Oct; 1(4):1721-8. PubMed ID: 23733703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension.
    Girerd B; Montani D; Eyries M; Yaici A; Sztrymf B; Coulet F; Sitbon O; Simonneau G; Soubrier F; Humbert M
    Respir Res; 2010 Jun; 11(1):73. PubMed ID: 20534176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Right ventricular systolic pressure response during exercise in adolescents born with atrial or ventricular septal defect.
    Möller T; Brun H; Fredriksen PM; Holmstrøm H; Peersen K; Pettersen E; Grünig E; Mereles D; Thaulow E
    Am J Cardiol; 2010 Jun; 105(11):1610-6. PubMed ID: 20494671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heritable forms of pulmonary arterial hypertension.
    Austin ED; Loyd JE
    Semin Respir Crit Care Med; 2013 Oct; 34(5):568-80. PubMed ID: 24037626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary artery hypertension in childhood: The transforming growth factor-β superfamily-related genes.
    Yuan SM
    Pediatr Neonatol; 2018 Apr; 59(2):112-119. PubMed ID: 28967497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Right ventricular pressure response to exercise in adults with isolated ventricular septal defect closed in early childhood.
    Moller T; Lindberg H; Lund MB; Holmstrom H; Dohlen G; Thaulow E
    Cardiol Young; 2018 Jun; 28(6):797-803. PubMed ID: 29508686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequence variants in BMPR2 and genes involved in the serotonin and nitric oxide pathways in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: relation to clinical parameters and comparison with left heart disease.
    Ulrich S; Szamalek-Hoegel J; Hersberger M; Fischler M; Garcia JS; Huber LC; Grünig E; Janssen B; Speich R
    Respiration; 2010; 79(4):279-87. PubMed ID: 19844076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of genetic mutation and modifier genes in pulmonary arterial hypertension].
    Fujiwara M; Yagi H; Matsuoka R; Saji T
    Nihon Rinsho; 2008 Nov; 66(11):2071-5. PubMed ID: 19051722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.